Occupational and environmental risk factors for Parkinson's disease.

The etiology of Parkinson's disease (PD) remains obscure. Current research suggests that a variety of occupational and environmental risk factors may be linked to PD. This paper provides an overview of major occupational and environmental factors that have been associated with the development of PD and tries to assess current thinking about these factors and their possible mechanisms of operation. While clear links to rural living, dietary factors, exposure to metals, head injury, and exposure to infectious diseases during childhood have not been established, there is general agreement that smoking and exposure to pesticides affect the probability of developing PD.

[1]  D. Calne,et al.  AETIOLOGY OF PARKINSON'S DISEASE , 1983, The Lancet.

[2]  C. Hertzman,et al.  Parkinson's disease: a case-control study of occupational and environmental risk factors. , 1990, American journal of industrial medicine.

[3]  Walter C. Willett Overview of Nutritional Epidemiology , 1998 .

[4]  H. Helenius,et al.  Environmental risk factors in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[5]  S. Khuder,et al.  A meta-analysis of Parkinson's disease and exposure to pesticides. , 2000, Neurotoxicology.

[6]  P. Newhouse,et al.  The effects of nicotine on Parkinson's disease. , 2000, Brain and cognition.

[7]  C. Osmond,et al.  Parkinson's disease and the environment in early life , 1995, Journal of the Neurological Sciences.

[8]  D. Calne,et al.  Occupational risk factors in Parkinson's disease. , 1999, Canadian journal of public health = Revue canadienne de sante publique.

[9]  D. Morens,et al.  Cigarette smoking and protection from Parkinson's disease , 1995, Neurology.

[10]  M. Catalán,et al.  Serum levels of β-carotene and other carotenoids in Parkinson's disease , 1993, Neuroscience Letters.

[11]  L. Grimberg PARALYSIS AGITANS AND TRAUMA , 1934 .

[12]  K. Fuxe,et al.  Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse , 1992, The clinical investigator.

[13]  D. Woitalla,et al.  High prevalence of parkinsonism after occupational exposure to lead‐sulfate batteries , 1998, Neurology.

[14]  L. Golbe,et al.  Follow‐up study of early‐life protective and risk factors in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[15]  H. Checkoway,et al.  Epidemiologic approaches to the study of Parkinson's disease etiology. , 1999, Epidemiology.

[16]  Satoshi Takahashi,et al.  Reduced and oxidized forms of glutathione and α-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after l-dopa treatment , 1995, Neuroscience Letters.

[17]  M. Murray,et al.  Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. , 1997, The Journal of pharmacology and experimental therapeutics.

[18]  S. Gruber,et al.  The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. , 1991 .

[19]  W. Koller,et al.  Environmental risk factors in siblings with Parkinson's disease. , 1991, Archives of neurology.

[20]  F. Jiménez-Jiménez,et al.  Risk‐factors for Parkinson's disease: case‐control study in the province of Cáceres, Spain , 1994, Acta neurologica Scandinavica.

[21]  M. Roy,et al.  Facteurs environnementaux dans l'étiologie de la maladie de Parkinson , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[22]  W. Weiner,et al.  Prior history of head trauma in Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[23]  D. Levy,et al.  PARKINSON'S DISEASE: A CLINICAL STUDY OF ONE HUNDRED AND FORTY-SIX CASES , 1922 .

[24]  C. Goetz,et al.  Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients , 1996, Neurology.

[25]  C. Hertzman,et al.  A case‐control study of Parkinson's disease in a horticultural region of British Columbia , 1994, Movement disorders : official journal of the Movement Disorder Society.

[26]  C. Tzourio,et al.  Smoking and Parkinson's disease , 1997, Neurology.

[27]  V. Hachinski,et al.  Environmental Exposures in Elderly Canadians With Parkinson’s Disease , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[28]  R. Marconi,et al.  Environmental and genetic risk factors in Parkinson's disease: A case–control study in southern italy , 1996, Movement disorders : official journal of the Movement Disorder Society.

[29]  J. Gorell,et al.  A Family History of Parkinson’s Disease and Its Effect on Other PD Risk Factors , 1999, Neuroepidemiology.

[30]  Environmental risk factors in Parkinson's disease , 1990, Neurology.

[31]  D. Morens,et al.  Smoking-associated protection from Alzheimer's and Parkinson's disease , 1994, The Lancet.

[32]  C. Martyn,et al.  Infection in childhood and neurological diseases in adult life. , 1997, British medical bulletin.

[33]  J. D. Poland,et al.  PARA‐ENCEPHALITIC PARKINSONISM , 1969, Acta neurologica Scandinavica.

[34]  Karen Marder,et al.  Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study , 1996, Annals of neurology.

[35]  G. Ulm,et al.  Diet and Parkinson's disease II , 1996, Neurology.

[36]  M. Quik,et al.  Nicotinic receptors and Parkinson's disease. , 2000, European journal of pharmacology.

[37]  E. Richfield,et al.  Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? , 2000, Brain Research.

[38]  H. Okada,et al.  The substantia nigra is a major target for neurovirulent influenza A virus , 1995, The Journal of experimental medicine.

[39]  M. Solioz,et al.  The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. , 1997, The Journal of pharmacology and experimental therapeutics.

[40]  H. Dorn Tobacco consumption and mortality from cancer and other diseases. , 1959, Acta - Unio Internationalis Contra Cancrum.

[41]  A. Seidler,et al.  Diet and Parkinson's disease I , 1996, Neurology.

[42]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[43]  C. Brayne,et al.  The Epidemiology of Parkinson’s Disease in an Australian Population , 1998, Neuroepidemiology.

[44]  C H Ngim,et al.  Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. , 1989, Neuroepidemiology.

[45]  G. Román,et al.  Worldwide occurrence of Parkinson's disease: an updated review. , 1993, Neuroepidemiology.

[46]  A. L. Werneck,et al.  Genetics, drugs and environmental factors in Parkinson's disease. A case-control study. , 1999, Arquivos de neuro-psiquiatria.

[47]  C. C. Johnson,et al.  The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.

[48]  M. Marmot,et al.  Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[49]  N. Benowitz,et al.  Basic and clinical psychopharmacology of nicotine. , 1991, Clinics in chest medicine.

[50]  C. C. Johnson,et al.  Smoking and Parkinson’s disease , 1999, Neurology.

[51]  X M Cheng,et al.  A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. , 1993, Neuroepidemiology.

[52]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[53]  A. Cohen,et al.  Memory of food intake in the distant past. , 1989, American journal of epidemiology.

[54]  K. Marder,et al.  Dietary iron, animal fats, and risk of Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[55]  D. Inzitari,et al.  Parkinson’s disease and parkinsonism in a longitudinal study , 2000, Neurology.

[56]  C. L. Wienburg,et al.  Organochlorine insecticides in substantia nigra in Parkinson's disease. , 2000, Journal of toxicology and environmental health. Part A.

[57]  J. R. Newton,et al.  Diagnosis and immediate prognosis of Japanese B encephalitis; observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases. , 1952, The American journal of medicine.

[58]  S. Ho,et al.  Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.

[59]  D. Eidelberg,et al.  Book Review Movement Disorders: Neurologic principles and practice Edited by Ray L. Watts and William C. Koller. 779 pp., illustrated. New York, McGraw-Hill, 1997. $125. 0-07-035203-8 , 1997 .

[60]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[61]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[62]  Klaus P. Ebmeier,et al.  Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza? , 1989, Journal of neurology, neurosurgery, and psychiatry.

[63]  R. Schwab,et al.  COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. , 1963, Journal of chronic diseases.

[64]  N. Noguchi,et al.  Effect of chlordane on hepatic mitochondrial respiration. , 1989, Toxicology letters.

[65]  The Effects of the Phosphorothioate Insecticide Fenitrothion on Mammalian Cytochrome P450-Dependent Metabolism of Estradiol , 1997 .

[66]  D. F. Metzler Health implications of organics in groundwater. , 1982, American journal of public health.

[67]  D. Morens,et al.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.

[68]  B. Hammock,et al.  The effect of tridiphane (2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane) on hepatic epoxide-metabolizing enzymes: indications of peroxisome proliferation. , 1987, Toxicology and applied pharmacology.

[69]  Y Ben-Shlomo,et al.  Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London , 2000, BMJ : British Medical Journal.

[70]  C. C. Johnson,et al.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. , 1999, Neurotoxicology.

[71]  R. Paffenbarger,et al.  Measles infection and Parkinson's disease. , 1985, American journal of epidemiology.

[72]  C. Marsden Parkinson's disease , 1940, The Lancet.

[73]  C. Tanner,et al.  Environmental factors and Parkinson's disease , 1989, Neurology.

[74]  C. C. Johnson,et al.  Adult nutrient intake as a risk factor for Parkinson's disease. , 1999, International journal of epidemiology.

[75]  M. Tardieu,et al.  Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes , 1996, Neurology.

[76]  Sanford P. Markey,et al.  Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.

[77]  R. Appleton,et al.  Encephalitis Lethargica‐like Illness in a Five‐year‐old , 1991, Developmental medicine and child neurology.

[78]  Peter M. M. Thygesen,et al.  Xenogenetics in multifactorial disease susceptibility. , 1995, Trends in genetics : TIG.

[79]  A. Smargiassi,et al.  A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. , 1998, Neurotoxicology.

[80]  E. Love,et al.  Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.

[81]  G. Barker,et al.  Magnetic resonance spectroscopic study of parkinsonism related to boxing. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[82]  R. Duvoisin,et al.  PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA. , 1963, Archives of neurology.

[83]  F. Hattori,et al.  Japanese encephalitis and parkinsonism , 2004, Journal of Neurology.

[84]  D. Schaid,et al.  Smoking, alcohol, and coffee consumption preceding Parkinson’s disease , 2000, Neurology.

[85]  E. Love,et al.  Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[86]  P. Vieregge,et al.  Long Term Exposure to Manganese in Rural Well Water Has No Neurological Effects , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[87]  D. Morens,et al.  Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. , 1996, American journal of epidemiology.

[88]  O. Axelson,et al.  Nutritional and occupational factors influencing the risk of Parkinson's disease: A case‐control study in southeastern Sweden , 1999, Movement disorders : official journal of the Movement Disorder Society.

[89]  A. Hofman,et al.  Incidence and risk factors of Parkinson's disease in The Netherlands. , 1989, Neuroepidemiology.

[90]  C. Hogstedt,et al.  Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury--a case-referent study. , 1981, Scandinavian journal of work, environment & health.

[91]  M. Ogata,et al.  Effect of heptachlor on hepatic mitochondrial oxidative phosphorylation in rat. , 1990, Industrial health.

[92]  J. Hubble,et al.  Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study , 1995, Journal of clinical microbiology.

[93]  T. Peng,et al.  Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.

[94]  C. Goetz,et al.  Trauma and movement disorders. , 1992, Neurologic clinics.

[95]  W. Foege,et al.  1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM , 1982, The Lancet.

[96]  L. Golbe,et al.  Kindreds of dominantly inherited Parkinson's disease: Keys to the riddle , 1995, Annals of neurology.

[97]  J. Oxford,et al.  Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Baron,et al.  Cigarette smoking and Parkinson's disease , 1986, Neurology.

[99]  J. Hubble,et al.  Risk factors for Parkinson's disease , 1993, Neurology.

[100]  C. Tanner,et al.  Environmental Factors in the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[101]  W. R. Brain Diseases of the Nervous System , 1892, Buffalo Medical and Surgical Journal.

[102]  A. Seidler,et al.  Smoking and Parkinson's disease: a case-control study in Germany. , 1997, International journal of epidemiology.

[103]  D. Maraganore Epidemiology and Genetics of Parkinson’s Disease , 2000 .

[104]  Z. J. Lipowski,et al.  Viruses, Immunity, and Mental Disorders , 1987, Springer US.

[105]  A. Aceto,et al.  Interaction of glutathione transferase P1-1 with captan and captafol. , 1996, Biochemical pharmacology.

[106]  T. Yamada,et al.  Viral etiology for Parkinson's disease--a possible role of influenza A virus infection. , 1999, Japanese journal of infectious diseases.

[107]  N. Wood,et al.  The genetics of Parkinson's disease. , 1999, Current opinion in neurology.

[108]  A. Moreno,et al.  Mitochondrial bioenergetics as affected by DDT. , 1991, Biochimica et biophysica acta.

[109]  C. Tzourio,et al.  Familial aggregation of Parkinson’s disease , 1999, Neurology.

[110]  W. T. Hung,et al.  Genetic and environmental risk factors for Parkinson’s disease in a Chinese population , 1998, Journal of neurology, neurosurgery, and psychiatry.

[111]  M. Druet‐Cabanac,et al.  Parkinson’s Disease and Environmental Factors , 2000, Neuroepidemiology.

[112]  H. Chapel,et al.  CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN , 1989, The Lancet.

[113]  J. Jeng,et al.  Environmental risk factors and Parkinson's disease , 1997, Neurology.

[114]  S. Fahn,et al.  Sequential parkinsonism and chorea following "mild" inluenza. , 1976, Transactions of the American Neurological Association.

[115]  K. Chaudhuri,et al.  Parkinson's disease in populations of African origin: a review. , 1996, Neuroepidemiology.

[116]  ANTENATAL DIAGNOSIS OF SPINA BIFIDA , 1973 .

[117]  F. Jiménez-Jiménez,et al.  Exposure to well water and pesticides in Parkinson's disease: A case‐control study in the madrid area , 1992, Movement disorders : official journal of the Movement Disorder Society.

[118]  Rakesh K. Gupta,et al.  Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. , 1999 .

[119]  B. Ritz,et al.  Parkinson's disease mortality and pesticide exposure in California 1984-1994. , 2000, International journal of epidemiology.

[120]  H. Checkoway,et al.  A pilot study of occupational and environmental risk factors for Parkinson's disease. , 1991, Neurotoxicology.

[121]  F. Jiménez-Jiménez,et al.  Serum levels of alpha‐tocopherol (vitamin E) in Parkinson's disease , 1992, Neurology.

[122]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[123]  L. Nashef,et al.  Acute parkinsonism in suspected herpes simplex encephalitis , 1993, Movement disorders : official journal of the Movement Disorder Society.

[124]  L. Abrey,et al.  Basal ganglia calcification after mumps encephalitis , 1996, Movement disorders : official journal of the Movement Disorder Society.

[125]  K. Marder,et al.  Smoking and Parkinson's disease. , 2004, Movement disorders : official journal of the Movement Disorder Society.

[126]  D. Morens,et al.  Case‐control study of idiopathic Parkinson's disease and dietary vitamin E intake , 1996, Neurology.

[127]  Gregory G. Brown,et al.  Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.

[128]  C. Marsden,et al.  α‐tocopherol levels in brain are not altered in Parkinson's disease , 1992 .

[129]  L. Golbe,et al.  Case-control study of early life dietary factors in Parkinson's disease. , 1988, Archives of neurology.

[130]  R. Marttila,et al.  Influenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls. , 1977, Archives of neurology.

[131]  R. G. Lee,et al.  Parkinson's disease , 1993, Neurology.

[132]  A. Seidler,et al.  Possible environmental, occupational, and other etiologic factors for Parkinson's disease , 1996, Neurology.

[133]  J. Jankovic,et al.  Peripherally induced tremor and parkinsonism. , 1995, Archives of neurology.

[134]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[135]  A. C. Collins,et al.  Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. , 1983, The Journal of pharmacology and experimental therapeutics.

[136]  H Checkoway,et al.  Dietary factors in Parkinson's disease: The role of food groups and specific foods , 1999, Movement disorders : official journal of the Movement Disorder Society.

[137]  M. Stern,et al.  Head trauma as a risk factor for Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[138]  J. Nutt,et al.  Environmental antecedents of young‐onset Parkinson's disease , 1993, Neurology.

[139]  E. Hodgson,et al.  Pesticides: an important but underused model for the environmental health sciences. , 1996, Environmental health perspectives.

[140]  H. Checkoway,et al.  A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease , 1998, Neurology.

[141]  S. Nakajima,et al.  Invasion of brain by neurovirulent influenza A virus after intranasal inoculation. , 1996, Parkinsonism & related disorders.